Brunt EM - Search Results

1

Lower serum hepcidin and greater parenchymal iron in nonalcoholic fatty liver disease patients with C282Y HFE mutations.

Nelson JE, Brunt EM, Kowdley KV; Nonalcoholic Steatohepatitis Clinical Research Network. Nelson JE, et al. Among authors: brunt em. Hepatology. 2012 Nov;56(5):1730-40. doi: 10.1002/hep.25856. Epub 2012 Sep 20. Hepatology. 2012. PMID: 22611049 Free PMC article.

2

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.

Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Brunt EM, et al. Am J Gastroenterol. 1999 Sep;94(9):2467-74. doi: 10.1111/j.1572-0241.1999.01377.x. Am J Gastroenterol. 1999. PMID: 10484010

3

Combination of interferon and ribavirin in chronic hepatitis C: re-treatment of nonresponders to interferon.

Di Bisceglie AM, Thompson J, Smith-Wilkaitis N, Brunt EM, Bacon BR. Di Bisceglie AM, et al. Among authors: brunt em. Hepatology. 2001 Mar;33(3):704-7. doi: 10.1053/jhep.2001.22346. Hepatology. 2001. PMID: 11230751 Clinical Trial.

4

Interim results of a pilot study demonstrating the early effects of the PPAR-gamma ligand rosiglitazone on insulin sensitivity, aminotransferases, hepatic steatosis and body weight in patients with non-alcoholic steatohepatitis.

Neuschwander-Tetri BA, Brunt EM, Wehmeier KR, Sponseller CA, Hampton K, Bacon BR. Neuschwander-Tetri BA, et al. Among authors: brunt em. J Hepatol. 2003 Apr;38(4):434-40. doi: 10.1016/s0168-8278(03)00027-8. J Hepatol. 2003. PMID: 12663234 Clinical Trial.

5

Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone.

Neuschwander-Tetri BA, Brunt EM, Wehmeier KR, Oliver D, Bacon BR. Neuschwander-Tetri BA, et al. Among authors: brunt em. Hepatology. 2003 Oct;38(4):1008-17. doi: 10.1053/jhep.2003.50420. Hepatology. 2003. PMID: 14512888 Clinical Trial.

6

Nonalcoholic steatohepatitis: histologic features and clinical correlations with 30 blinded biopsy specimens.

Brunt EM, Neuschwander-Tetri BA, Oliver D, Wehmeier KR, Bacon BR. Brunt EM, et al. Hum Pathol. 2004 Sep;35(9):1070-82. doi: 10.1016/j.humpath.2004.04.017. Hum Pathol. 2004. PMID: 15343508 Clinical Trial.

7

Effect of significant histologic steatosis or steatohepatitis on response to antiviral therapy in patients with chronic hepatitis C.

Harrison SA, Brunt EM, Qazi RA, Oliver DA, Neuschwander-Tetri BA, Di Bisceglie AM, Bacon BR. Harrison SA, et al. Among authors: brunt em. Clin Gastroenterol Hepatol. 2005 Jun;3(6):604-9. doi: 10.1016/s1542-3565(05)00246-6. Clin Gastroenterol Hepatol. 2005. PMID: 15952103

8

The effects of 48 weeks of rosiglitazone on hepatocyte mitochondria in human nonalcoholic steatohepatitis.

Caldwell SH, Patrie JT, Brunt EM, Redick JA, Davis CA, Park SH, Neuschwander-Tetri BA. Caldwell SH, et al. Among authors: brunt em. Hepatology. 2007 Oct;46(4):1101-7. doi: 10.1002/hep.21813. Hepatology. 2007. PMID: 17661371

9

Pathology of nonalcoholic fatty liver disease.

Yeh MM, Brunt EM. Yeh MM, et al. Among authors: brunt em. Am J Clin Pathol. 2007 Nov;128(5):837-47. doi: 10.1309/RTPM1PY6YGBL2G2R. Am J Clin Pathol. 2007. PMID: 17951208 Review.

10

Relationship of steatosis grade and zonal location to histological features of steatohepatitis in adult patients with non-alcoholic fatty liver disease.

Chalasani N, Wilson L, Kleiner DE, Cummings OW, Brunt EM, Unalp A; NASH Clinical Research Network. Chalasani N, et al. Among authors: brunt em. J Hepatol. 2008 May;48(5):829-34. doi: 10.1016/j.jhep.2008.01.016. Epub 2008 Feb 12. J Hepatol. 2008. PMID: 18321606 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

312 results

Search Page

Filters